Combination radionuclide therapy: A new paradigm
dc.contributor.author | Suman, S. K. | |
dc.contributor.author | Subramanian, S. | |
dc.contributor.author | Mukherjee, A. | |
dc.date.accessioned | 2022-08-02T10:37:14Z | |
dc.date.available | 2022-08-02T10:37:14Z | |
dc.date.issued | 2021 | |
dc.description.division | RPhD | en |
dc.format.extent | 4771 bytes | |
dc.format.mimetype | text/html | |
dc.identifier.source | Nuclear Medicine and Biology, 2021. Vol. 98-99: pp. 40-58 | en |
dc.identifier.uri | http://hdl.handle.net/123456789/24886 | |
dc.language.iso | en | en |
dc.subject | Molecular radionuclide therapy | en |
dc.subject | Combination radionuclide therapy | en |
dc.subject | Therapeutic radiopharmaceuticals | en |
dc.subject | Radioimmunotherapy | en |
dc.subject | Peptide receptor radionuclide therapy | en |
dc.title | Combination radionuclide therapy: A new paradigm | en |
dc.type | Article | en |